These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15648301)

  • 1. [Selection and pharmacological characterisation of Procoralan, a selective inhibitor of the pacemaker If current].
    Vilaine JP
    Therapie; 2004; 59(5):495-505. PubMed ID: 15648301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The discovery of the selective If current inhibitor ivabradine (Procoralan): a new therapeutic approach to ischemic heart disease].
    Vilaine JP
    Med Sci (Paris); 2006 Jan; 22(1):87-94. PubMed ID: 16386229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease.
    Vilaine JP
    Pharmacol Res; 2006 May; 53(5):424-34. PubMed ID: 16638639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257.
    Thollon C; Bidouard JP; Cambarrat C; Lesage L; Reure H; Delescluse I; Vian J; Peglion JL; Vilaine JP
    Eur J Pharmacol; 1997 Nov; 339(1):43-51. PubMed ID: 9450615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.
    Thollon C; Bedut S; Villeneuve N; Cogé F; Piffard L; Guillaumin JP; Brunel-Jacquemin C; Chomarat P; Boutin JA; Peglion JL; Vilaine JP
    Br J Pharmacol; 2007 Jan; 150(1):37-46. PubMed ID: 17128289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ivabradine (Procoralan)].
    Lancellotti P
    Rev Med Liege; 2008 Apr; 63(4):220-4. PubMed ID: 18575078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ischaemic effect of ivabradine.
    Ferrari R; Cargnoni A; Ceconi C
    Pharmacol Res; 2006 May; 53(5):435-9. PubMed ID: 16644235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49.
    Thollon C; Cambarrat C; Vian J; Prost JF; Peglion JL; Vilaine JP
    Br J Pharmacol; 1994 May; 112(1):37-42. PubMed ID: 8032660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate reduction by pharmacological If current inhibition.
    Cargnoni A; Ceconi C; Stavroula G; Ferrari R
    Adv Cardiol; 2006; 43():31-44. PubMed ID: 16936470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICI D7288, a novel sinoatrial node modulator.
    Marshall PW; Rouse W; Briggs I; Hargreaves RB; Mills SD; McLoughlin BJ
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):902-6. PubMed ID: 7687714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradycardic and proarrhythmic properties of sinus node inhibitors.
    Stieber J; Wieland K; Stöckl G; Ludwig A; Hofmann F
    Mol Pharmacol; 2006 Apr; 69(4):1328-37. PubMed ID: 16387796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate slowing for myocardial dysfunction/heart failure.
    Mulder P; Thuillez C
    Adv Cardiol; 2006; 43():97-105. PubMed ID: 16936475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L; Simonsen U; Grimm D; Hedegaard ER
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC
    Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis.
    Busseuil D; Shi Y; Mecteau M; Brand G; Gillis MA; Thorin E; Asselin C; Roméo P; Leung TK; Latour JG; Des Rosiers C; Bouly M; Rhéaume E; Tardif JC
    Cardiology; 2010; 117(3):234-42. PubMed ID: 21212673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.